...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Promissory Notes

Section 5 (Promissory Notes) of the April 6 "Interim financial statements/report" is an interesting read.

 

Share
New Message
Please login to post a reply